(VIANEWS) – The Market ended the session with ADOCIA (ADOC.PA) rising 13.4% to €6.60 on Wednesday, following the last session’s upward trend. CAC 40 dropped 0.4% to €7,492.00, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
ADOCIA’s last close was €5.82, 63.99% below its 52-week high of €16.16.
About ADOCIA
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Earnings Per Share
As for profitability, ADOCIA has a trailing twelve months EPS of €-1.5.
Moving Average
ADOCIA’s worth is way under its 50-day moving average of €7.63 and way under its 200-day moving average of €8.82.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADOCIA’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
ADOCIA’s stock is valued at €6.60 at 22:30 EST, way under its 52-week high of €16.16 and way higher than its 52-week low of €5.11.
More news about ADOCIA (ADOC.PA).
